HanesBrands (HBI) M&A Announcement summary
Event summary combining transcript, slides, and related documents.
M&A Announcement summary
25 Nov, 2025Deal rationale and strategic fit
The merger creates a global leader in basic apparel, expanding scale, product diversification, and leveraging iconic brands and a vertically integrated, low-cost manufacturing network.
Enhanced go-to-market and retail capabilities, broader consumer reach, and balanced exposure across categories and channels are expected.
The combined entity leverages complementary strengths in activewear and innerwear, with highly aligned product categories, manufacturing footprints, and customer bases.
Enhanced resiliency to seasonal and cyclical variations and reinforced global low-cost manufacturing footprint.
Financial terms and conditions
HanesBrands shareholders will receive 0.102 Gildan shares and $0.80 in cash per HanesBrands share, valuing HanesBrands at $6 per share and a total enterprise value of $4.4 billion.
The offer represents a 24% premium to HanesBrands' closing price and an EV/EBITDA multiple of 8.9x (6.3x including synergies).
The transaction is approximately 87% stock and 13% cash, with the cash portion totaling about $290 million.
Gildan has secured $2.3 billion in committed financing and expects to refinance HanesBrands' $2 billion in debt.
HanesBrands shareholders will own about 19.9% of the combined company upon closing.
Synergies and expected cost savings
The merger targets at least $200 million in annual run-rate cost synergies within three years: $50 million in 2026, $100 million in 2027, and $50 million in 2028.
Synergies will be driven by manufacturing optimization, SG&A reductions, logistics, IT consolidation, and leveraging available capacity.
Synergies will enhance EBITDA margins from 20% to 23% pro forma.
One-time costs to capture synergies are estimated at $200 million.
No synergies are attributed to the Australia business, which is under strategic review for potential divestiture.
Latest events from HanesBrands
- Adjusted profit and margin growth drive strong Q2; Champion sale to fund $1B debt paydown.HBI
Q2 20242 Feb 2026 - Record margin, profit growth, and debt reduction set the stage for continued improvement.HBI
Q3 202416 Jan 2026 - Sales, margins, and cash flow exceeded expectations; 2025 targets margin gains and lower leverage.HBI
Q4 202422 Dec 2025 - Gildan to acquire Hanesbrands, offering a premium and fixed exchange ratio to stockholders.HBI
Proxy Filing1 Dec 2025 - 2024 saw margin growth, debt reduction, and ESG progress; key votes include board, pay, and equity plan.HBI
Proxy Filing1 Dec 2025 - Definitive proxy materials filed for shareholder voting, with no fee required.HBI
Proxy Filing1 Dec 2025 - Q2 2025 profit and margin gains drove a raised full-year outlook amid ongoing cost savings.HBI
Q2 202523 Nov 2025 - Q1 2025 saw higher sales, margin gains, and improved leverage despite tariff and market headwinds.HBI
Q1 202520 Nov 2025 - Operating profit up 14% and EPS surged on tax benefit, with Gildan acquisition pending.HBI
Q3 20256 Nov 2025